A monitoring visit of the study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness in Marin, Calif., is scheduled to take place from June 7- 8, 2018. Clinical Operations Manager Rebecca Matthews and Clinical Research Associate Alia Lilienstein of MAPS will conduct the closeout visits. Led by Principal Investigator Phil Wolfson, M.D., with Co-Therapist Julane Andries, L.M.F.T., this study is gathering preliminary data about the safety and efficacy of MDMA-assisted psychotherapy for anxiety associated with a diagnosis of a life-threatening illness. Learn more…
